Literature DB >> 28965382

[Seminal vesiculoscopy in the treatment of refractory hemospermia and ejaculatory duct obstruction].

Jun Zhao1, Xiao-Qiang Zhai1, He-Cheng Li1, Tie Chong1.   

Abstract

Objective: To summarize the experience in the diagnosis and treatment of refractory hematospermia and ejaculatory duct obstruction by seminal vesiculoscopy.
METHODS: We retrospectively analyzed the clinical data about 42 cases of refractory hematospermia and 6 cases of ejaculatory duct obstruction with azoospermia. We investigated the diagnosis, treatment, and prognosis of the diseases.
RESULTS: All the patients underwent pelvic MRI and seminal vesiculoscopy. MRI for the 42 refractory hematospermia patients showed that 21 (50.0%) had cystic dilatation in the uni- or bilateral seminal vesicles, 25 (59.5%) had abnormal internal signal intensity in the uni- or bilateral seminal vesicles, 12 (28.6%) had both the problems above, and 4 (9.52%) had no obvious abnormality in the seminal vesicle area. The bilateral seminal vesicles were <1 cm in width in 3 of the 6 cases of ejaculatory duct obstruction, and obviously enlarged in the other 3, but without abnormal internal signals. No recurrence was found during the 3-36 months follow-up.
CONCLUSIONS: The history and physical examination play important roles in the diagnosis of refractory hemospermia, and MRI is more valuable than TRUS in the diagnosis of seminal vesicle diseases. Seminal vesiculoscopy is an effective option for the management of persistent hematospermia and ejaculatory duct obstruction.

Entities:  

Keywords:  MRI; ejaculatory duct obstruction; hematospermia; seminal vesiculoscopy

Mesh:

Year:  2016        PMID: 28965382

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  1 in total

1.  A Comparative Study on the Success Rates of Two Approaches for Seminal Vesiculoscopy.

Authors:  Tao Zheng; Tian-Biao Zhang; Kun-Long Lv; Yong-Hao Nan; Yong-Fei Liu; Ya-Wei Hao; Jie Zhang; Rui Wang
Journal:  Am J Mens Health       Date:  2022 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.